Clinical Trial Update: An Extension of the CONCERT Protocol (DIM18) [Phase 3]

View source ↗

Summary

Notes termination of the DIM18 extension of the CONCERT protocol in a Phase 3 trial for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Medivation, Inc. | Conditions: Alzheimer's Disease | Phase 3 | Status: TERMINATED